In lung and breast cancer animal models, citrate treatments inhibited tumor growth by suppressing the insulin-like growth factor type 1 receptor (IGF-1R)/AKT/PTEN/eukaryotic translation initiation factor 2A (eIF2A) pathway [22]. This evidence concerns the gene IGF1R and breast carcinoma.